Adhera Therapeutics, Inc. (ATRX)
OTCMKTS: ATRX · Delayed Price · USD
0.0060
0.00 (0.00%)
Apr 19, 2024, 3:12 PM EDT - Market closed
Adhera Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 0 | 2 | 1 | 0 | 1 | 3 | 16 | 7 | 7 | 16 | 7 | Upgrade
|
| Market Cap Growth | - | 107.86% | 101.66% | -30.61% | -78.57% | -81.30% | 128.11% | 0.18% | -56.32% | 139.98% | 17.43% | Upgrade
|
| Enterprise Value | 11 | 10 | 7 | 7 | 6 | -1 | 18 | 8 | 6 | 14 | 7 | Upgrade
|
| PE Ratio | -0.01 | 0.80 | -0.12 | -0.08 | -0.05 | -0.18 | -2.61 | -8.50 | 2.13 | -2.51 | -4.31 | Upgrade
|
| PS Ratio | - | - | - | - | 2.58 | 39.83 | - | - | 10.44 | 32.52 | 3.20 | Upgrade
|
| PB Ratio | 0.00 | -0.09 | -0.04 | -0.03 | -0.07 | 1.04 | 36.21 | 2.21 | 27.00 | -3.72 | -0.96 | Upgrade
|
| P/FCF Ratio | -0.16 | -1.34 | -1.37 | -0.77 | -0.07 | -0.31 | -9.92 | -13.62 | -3.21 | -3.40 | 23.77 | Upgrade
|
| P/OCF Ratio | -0.16 | -1.34 | -1.37 | -0.77 | -0.07 | -0.32 | -12.87 | -13.62 | -3.28 | -3.40 | 23.77 | Upgrade
|
| EV/Sales Ratio | - | - | - | - | 23.53 | -11.60 | - | - | 9.40 | 28.87 | 3.54 | Upgrade
|
| EV/EBITDA Ratio | -6.30 | -6.46 | -9.20 | -3.40 | -0.59 | 0.08 | -3.20 | -10.86 | -1.60 | -4.10 | -20.52 | Upgrade
|
| EV/EBIT Ratio | -3.24 | -3.05 | -6.18 | -2.83 | -0.58 | 0.08 | -2.96 | -10.16 | - | - | -3.16 | Upgrade
|
| EV/FCF Ratio | -13.52 | -7.38 | -11.27 | -11.51 | -0.68 | 0.09 | -11.02 | -14.73 | -2.89 | -3.02 | 26.28 | Upgrade
|
| Debt / Equity Ratio | -0.41 | -0.39 | -0.27 | -0.43 | -0.54 | 0 | 4.25 | 0.21 | 0 | 0 | -0.23 | Upgrade
|
| Debt / EBITDA Ratio | -6.24 | -5.31 | -8.18 | -3.17 | -0.53 | - | -0.34 | -0.97 | - | - | -4.45 | Upgrade
|
| Debt / FCF Ratio | -13.40 | -6.07 | -10.02 | -10.74 | -0.61 | - | -1.17 | -1.31 | - | - | 5.69 | Upgrade
|
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.79 | 0.02 | 0.04 | 0.29 | 1.20 | 0.15 | Upgrade
|
| Current Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.04 | 2.11 | 0.02 | 0.11 | 0.35 | 1.30 | 0.17 | Upgrade
|
| Asset Turnover | 0 | 0 | 0 | 0 | 0.60 | 0.01 | 0 | 0 | 0.09 | 0.05 | 0.27 | Upgrade
|
| Interest Coverage | -0.45 | -0.51 | -0.47 | -1.15 | -17.09 | -105.37 | -47.61 | -215.69 | -3989.00 | -3.50 | -1.47 | Upgrade
|
| Return on Equity (ROE) | 9.61% | -10.60% | 31.00% | 37.50% | 127.84% | -572.48% | -1387.49% | -26.01% | 1268.82% | 148.18% | 22.24% | Upgrade
|
| Return on Assets (ROA) | -5737.66% | 2977.22% | -3971.43% | -554000.00% | -3009.52% | -325.92% | -100.58% | -13.53% | 43.94% | -70.28% | -20.29% | Upgrade
|
| Return on Capital (ROIC) | 8.26% | 11.90% | 3.65% | 24.09% | 248.32% | -539.68% | -258.68% | -19.41% | -4846.99% | 80.53% | 6.71% | Upgrade
|
| Earnings Yield | -5836.85% | 124.31% | -855.15% | -1227.36% | -1943.27% | -552.09% | -38.32% | -11.77% | 46.99% | -39.84% | -23.19% | Upgrade
|
| FCF Yield | -1865.33% | -74.79% | -73.06% | -130.27% | -1343.37% | -319.15% | -10.08% | -7.34% | -31.12% | -29.39% | 4.21% | Upgrade
|
| Dividend Yield | 25.02% | 32.77% | 225.65% | 341.18% | 231.38% | 35.06% | 0.00% | 0.00% | 9.72% | 36.90% | 0.00% | Upgrade
|
| Payout Ratio | 34.80% | 26.36% | -26.39% | -27.80% | -11.91% | -6.35% | 0.00% | 0.00% | 20.68% | -92.64% | 0.00% | Upgrade
|
| Buyback Yield / Dilution | -36.16% | -254.91% | -19.56% | -0.33% | -0.02% | -10.19% | -107.38% | -44.28% | -33.45% | -45.44% | -26.24% | Upgrade
|
| Total Shareholder Return | -36.16% | -222.14% | 206.09% | 340.85% | 231.36% | 24.87% | -107.38% | -44.28% | -23.73% | -8.54% | -26.24% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.